Checking for a Treatment Target in Acute Brain Bleeding
Tests a dye-based scan of brain blood vessels in adults with sudden brain bleeding.
Plain-language title generated from the registry record
Registry title: Detection of an Endovascular Treatment Target in Patients With an Acute, Spontaneous Intracerebral Hemorrhage
Key facts
- Where
- Basel, SwitzerlandSee the site
Where in Switzerland
- Department of Neuroradiology, University Hospital BaselBasel, SwitzerlandTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- University Hospital, Basel, Switzerland
- Trial code
- NCT05504941
- Record updated
- 11 April 2025
- Original description
This study is to determine if a treatment target for a potential endovascular therapy exists in patients with an acute, spontaneous (non-traumatic) ICH.Read full original descriptionShow less
Detection of an Endovascular Treatment Target in Patients With an Acute, Spontaneous Intracerebral Hemorrhage - an EXPLOrative Pilot Study (HemEXPLO)
This study is to determine if a treatment target for a potential endovascular therapy exists in patients with an acute, spontaneous (non-traumatic) ICH.
Inclusion: Diagnosis of an acute spontaneous ICH based on non-contrast CT; Time from symptom onset to anticipated start of cerebral DSA of under 3 hours; Agreement of the treating physician to perform DSA; Informed consent documented by signature or fulfilling the criteria for emergency consent procedures (deferral of consent).
Exclusion: Any time critical surgical or minimal invasive intervention is planned; High probability that the etiology of the bleeding is a ruptured aneurysm, an arteriovenous malformation or an amyloid angiopathy as judged by the treating physician; Known severe kidney insufficiency (Glomerular filtration rate < 30 ml/min); Evidence of an ongoing pregnancy, a negative pregnancy test is mandatory in all persons of childbearing potential; Contraindications against the use of iodine contrast media.